Eligard and Hospitalisation - from FDA reports


Summary

Hospitalisation is found among people who take Eligard, especially for people who are male, 60+ old , have been taking the drug for 2 - 5 years, also take medication Xtandi, and have Prostate cancer metastatic. This review analyzes which people have Hospitalisation with Eligard. It is created by eHealthMe based on reports of 4,172 people who have side effects when taking Eligard from FDA , and is updated regularly.

What to expect?

If you take Eligard and have Hospitalisation, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Eligard and have Hospitalisation

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 02, 2017

4,172 people reported to have side effects when taking Eligard.
Among them, 79 people (1.89%) have Hospitalisation


Number of reports submitted per year:

Could Eligard cause Hospitalisation?

Time on Eligard when people have Hospitalisation *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 15.79 %
  • 6 - 12 months: 10.53 %
  • 1 - 2 years: 10.53 %
  • 2 - 5 years: 47.37 %
  • 5 - 10 years: 15.79 %
  • 10+ years: 0.0 %

Gender of people who have Hospitalisation when taking Eligard *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Hospitalisation when taking Eligard *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  • Prostate Cancer Recurrent (1 person, 1.27%)
  • Prostate Cancer Metastatic (1 person, 1.27%)

Top co-used drugs for these people *:

  • Xtandi (3 people, 3.80%)
  • Zytiga (2 people, 2.53%)
  • Zofran (1 person, 1.27%)
  • Zocor (1 person, 1.27%)
  • Xgeva (1 person, 1.27%)

Top other side effects for these people *:

  • Death (13 people, 16.46%)
  • Drug Intolerance (2 people, 2.53%)
  • Urinary Bladder Haemorrhage (1 person, 1.27%)
  • Skull Fracture (1 person, 1.27%)
  • Malignant Neoplasm Progression (1 person, 1.27%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Hospitalisation when taking Eligard?

Expand the study to include all drugs with the same ingredients

Hospitalisation and drugs with ingredients of leuprolide acetate.

Expand the study to include reports from both FDA and eHealthMe

Hospitalisation and Eligard from FDA and eHealthMe reports

Eligard

Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. (latest outcomes from Eligard 4,198 users)

Hospitalisation

Hospitalisation has been reported by people with hyperparathyroidism secondary, osteoporosis, rheumatoid arthritis, crohn's disease, preventive health care (latest reports from 42,138 Hospitalisation patients).

Browse all side effects of Eligard

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Hospitalisation

Hospitalisation

Could your condition cause Hospitalisation

Hospitalisation

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Eligard and have Hospitalisation.

User reviews to the study

More reviews >